BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35454044)

  • 1. Single-Cell Sequencing: Ariadne's Thread in the Maze of Acute Myeloid Leukemia.
    Redavid I; Conserva MR; Anelli L; Zagaria A; Specchia G; Musto P; Albano F
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic heterogeneity and clonal evolution in acute myeloid leukemia.
    Romer-Seibert JS; Meyer SE
    Curr Opin Hematol; 2021 Jan; 28(1):64-70. PubMed ID: 33186150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ariadne's thread: a promising new multidisciplinary tool to foster clients' resilience throughout the rehabilitation process.
    Royer N; Bourdages-Perreault L; Cornelier G; Coutya J; Naud JM; Chouinard J; Levasseur M
    Disabil Rehabil; 2016 Jul; 38(15):1454-62. PubMed ID: 26694023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo Models.
    Desai RH; Zandvakili N; Bohlander SK
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias.
    Duchmann M; Laplane L; Itzykson R
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia.
    Nuno KA; Azizi A; Köhnke T; Lareau CA; Ediwirickrema A; Ryan Corces M; Satpathy AT; Majeti R
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating the leukocyte signaling maze guided by Ariadne's thread.
    Altman A; Koretzky GA; Tsoukas CD
    Nat Immunol; 2009 Nov; 10(11):1134-6. PubMed ID: 19841642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing.
    Chen A; Hu S; Wang QF
    Blood Sci; 2019 Aug; 1(1):73-76. PubMed ID: 35402804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.
    Paguirigan AL; Smith J; Meshinchi S; Carroll M; Maley C; Radich JP
    Sci Transl Med; 2015 Apr; 7(281):281re2. PubMed ID: 25834112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of mutations and clonal evolution patterns in a cohort of patients with cytogenetically normal acute myeloid leukemia.
    Mat Yusoff Y; Ahid F; Abu Seman Z; Abdullah J; Kamaluddin NR; Esa E; Zakaria Z
    Mol Cytogenet; 2021 Sep; 14(1):45. PubMed ID: 34560908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy.
    Castelli G; Pelosi E; Testa U
    Onco Targets Ther; 2018; 11():131-155. PubMed ID: 29343972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis.
    Dillon LW; Ghannam J; Nosiri C; Gui G; Goswami M; Calvo KR; Lindblad KE; Oetjen KA; Wilkerson MD; Soltis AR; Sukumar G; Dalgard CL; Thompson J; Valdez J; DeStefano CB; Lai C; Sciambi A; Durruthy-Durruthy R; Llanso A; Gulati S; Wang S; Ooi A; Dagur PK; McCoy JP; Burr P; Li Y; Hourigan CS
    Blood Cancer Discov; 2021 Jul; 2(4):319-325. PubMed ID: 34258102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic determinants of AML pathogenesis.
    Cai SF; Levine RL
    Semin Hematol; 2019 Apr; 56(2):84-89. PubMed ID: 30926095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
    Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
    J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Ariadne's Thread": Psycho-educational Empowerment Intervention for Patients with Metastatic Breast Cancer.
    Alfieri S; Murru L; Bosisio M; Gangeri L; Monfredini M; Capri G; Lozza L; Borreani C
    J Cancer Educ; 2024 May; ():. PubMed ID: 38809494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell mutational profiling enhances the clinical evaluation of AML MRD.
    Ediriwickrema A; Aleshin A; Reiter JG; Corces MR; Köhnke T; Stafford M; Liedtke M; Medeiros BC; Majeti R
    Blood Adv; 2020 Mar; 4(5):943-952. PubMed ID: 32150611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
    Eriksson A; Lennartsson A; Lehmann S
    Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Precision medicine for acute myeloid leukemia based on genomic profiling].
    Sanada M
    Rinsho Ketsueki; 2019; 60(7):847-853. PubMed ID: 31391376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.